US Health & Fitness
Regulatory pressure is mounting on Amgen’s inflammatory disorder drug, Tavneos, with the European Medicines Agency recommending revocation of the product’s approval in its territory.…
As a Sanofi veteran, Frédéric Marrache is well aware of the innovations shaping immunology. His…
The case that many startups are making for automating the healthcare revenue cycle is pretty…
In January 2026, CMS launched the Wasteful and Inappropriate Service Reduction (WISeR) model, introducing prior…
America funds the crisis. It’s time to fund the care that prevents it. The post…
For both the builders and users of clinical AI, bias remains one of the single…
The Medicare Advantage (MA) program has long occupied a unique space as a true public-private…
